drugset / Trial / NCT00559962
Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS
RandomizedParallel-groupTriple-blindTreatment
Summary
To determine safety and effectiveness of low-dose therapeutic AEGR-733 +/- atorvastatin, ezetimibe or fenofibrate (compared to placebo) on liver fat accumulation measured by Magnetic Resonance Spectroscopy
Timeline
- Start
- 2007-10
- Primary completion
- 2008-10
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | 20 mg | — |
| Comparator | Ezetimibe | Unknown | 10 mg | — |
| Comparator | Fenofibrate | Small molecule | 145 mg | — |
| Comparator | lomitapide | Small molecule | 2.5 mg | — |
| Comparator | lomitapide | Small molecule | 5 mg | — |
| Comparator | lomitapide | Small molecule | 7.5 mg | — |
| Comparator | lomitapide | Small molecule | 10 mg | — |